These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 395139)

  • 21. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
    Jones RB; Matthes S; Shpall EJ; Fisher JH; Stemmer SM; Dufton C; Stephens JK; Bearman SI
    J Natl Cancer Inst; 1993 Apr; 85(8):640-7. PubMed ID: 8468721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemolytic uremic syndrome after autologous BMT without TBI.
    Raybon KB; Snyder MJ; Halvorson RD
    Bone Marrow Transplant; 1996 May; 17(5):897-8. PubMed ID: 8733719
    [No Abstract]   [Full Text] [Related]  

  • 23. Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Robertson MJ; Abonour R; Hromas R; Nelson RP; Fineberg NS; Cornetta K
    Leuk Lymphoma; 2005 Oct; 46(10):1477-87. PubMed ID: 16194894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
    Adkins DR; Salzman D; Boldt D; Kuhn J; Irvin R; Roodman GD; Lyons R; Smith L; Freytes CO; LeMaistre CF
    J Clin Oncol; 1994 Sep; 12(9):1890-901. PubMed ID: 7916039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bone marrow organ: the critical structure in radiation-drug interaction. Sir Stanford Cade Memorial lecture.
    Rubin P; Scarantino CW
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):3-23. PubMed ID: 344290
    [No Abstract]   [Full Text] [Related]  

  • 26. Fatal veno-occlusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and autologous bone marrow transplantation.
    McIntyre RE; Magidson JG; Austin GE; Gale RP
    Am J Clin Pathol; 1981 Apr; 75(4):614-7. PubMed ID: 7013473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell maneuvers target bone marrow toxicity.
    Randal J
    J Natl Cancer Inst; 1999 Sep; 91(18):1530-2. PubMed ID: 10491422
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
    Wheeler C; Antin JH; Churchill WH; Come SE; Smith BR; Bubley GJ; Rosenthal DS; Rappaport JM; Ault KA; Schnipper LE
    J Clin Oncol; 1990 Apr; 8(4):648-56. PubMed ID: 2313334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's disease.
    Spinolo JA; Jagannath S; Velásquez W; Spitzer G; Cabanillas F; Hagemeister F; Horwitz LJ; Dicke KA
    Leuk Lymphoma; 1993 Jan; 9(1-2):71-7. PubMed ID: 8477204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.
    Hochberg FH; Parker LM; Takvorian T; Canellos GP; Zervas NT
    J Neurosurg; 1981 Apr; 54(4):455-60. PubMed ID: 6259300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
    McQuaker IG; Haynes AP; Iqbal A; Russell NH
    Bone Marrow Transplant; 1996 Jul; 18(1):263-4. PubMed ID: 8832036
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 33. Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain.
    Honess DJ; Bleehen NM
    Br J Cancer; 1982 Aug; 46(2):236-48. PubMed ID: 6758828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
    Yeager AM; Kaizer H; Santos GW; Saral R; Colvin OM; Stuart RK; Braine HG; Burke PJ; Ambinder RF; Burns WH
    N Engl J Med; 1986 Jul; 315(3):141-7. PubMed ID: 3523241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy study for remission maintenance in ALL: an evaluation of vincristine, cyclophosphamide and vincristine, cyclophosphamide, and BCNU: a Southwest Oncology Group Phase II Study.
    Sexauer CL; Vietti T; Humphrey GB
    Am J Pediatr Hematol Oncol; 1981; 3(3):255-7. PubMed ID: 6945060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease.
    Ahmed T; Ciavarella D; Feldman E; Ascensao J; Hussain F; Engelking C; Gingrich S; Mittelman A; Coleman M; Arlin ZA
    Leukemia; 1989 Jan; 3(1):19-22. PubMed ID: 2642573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent.
    Vaughan WP; Bierman PJ; Reed EC; Glenn LD; Kessinger A; Armitage JO
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):110-5. PubMed ID: 1641652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. delta-Aminolevulinate dehydratase activity and oxidative stress during melphalan and cyclophosphamide-BCNU-etoposide (CBV) conditioning regimens in autologous bone marrow transplantation patients.
    Gonçalves TL; Benvegnú DM; Bonfanti G; Frediani AV; Rocha JB
    Pharmacol Res; 2009 Apr; 59(4):279-84. PubMed ID: 19162187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation.
    Stewart FM; Kaiser DL; Ishitani KP; Pirsch GW; Niskanen E
    Exp Hematol; 1989 Oct; 17(9):974-80. PubMed ID: 2673831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.
    Mbidde EK; Selby PJ; Perren TJ; Dearnaley DP; Whitton A; Ashley S; Workman P; Bloom HJ; McElwain TJ
    Br J Cancer; 1988 Dec; 58(6):779-82. PubMed ID: 2852028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.